Methods for cloning amplified nucleic acid molecules

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S091100, C435S091500, C435S091520

Reexamination Certificate

active

07736874

ABSTRACT:
The present invention is directed generally to methods facilitating the cloning of nucleic acid molecules. In particular, the invention relates to the use of polymerase inhibitors, including but not limited to anti-polymerase antibodies (such as anti-Taq antibodies) and fragments thereof, to inactivate residual polymerase activity remaining after the amplification (particularly via PCR) of a target nucleic acid molecule. The invention further provides compositions, particularly storage-stable compositions, comprising one or more components, such as one or more restriction endonucleases and one or more polymerase inhibitors, that are useful in cloning amplified or synthesized nucleic acid molecules by the above-described methods. The invention also relates to nucleic acid molecules produced by these methods, and to genetic constructs (such as vectors) and host cells comprising these nucleic acid molecules.

REFERENCES:
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5338671 (1994-08-01), Scalice et al.
patent: 5436149 (1995-07-01), Barnes
patent: 5487993 (1996-01-01), Herrnstadt
patent: 5512462 (1996-04-01), Cheng
patent: 5565340 (1996-10-01), Chenchik et al.
patent: 5587287 (1996-12-01), Scalice et al.
patent: 5814502 (1998-09-01), Hoeltke et al.
patent: 5827657 (1998-10-01), Herrnstadt et al.
patent: 6140086 (2000-10-01), Fox et al.
patent: 6830902 (2004-12-01), Astatke et al.
patent: 2002/0028447 (2002-03-01), Li et al.
patent: WO 92/06188 (1992-04-01), None
patent: WO 92/06200 (1992-04-01), None
patent: WO 96/10640 (1996-04-01), None
patent: WO 97/24455 (1997-07-01), None
patent: WO 99/09197 (1999-02-01), None
Mead, D. et al. A universal method for the direct cloning of PCR amplified nucleic acid. Bio/technology 9(7):657-663 (Jul. 1991).
Zhou, M.-Y. et al. BioTechniques 19(1):34-35 (Jul. 1995).
Magnuson, V.L. et al. BioTechniques 21(4):700-709 (Oct. 1996).
Barnes, W.M., “The fidelity ofTaqpolymerase catalyzing PCR is improved by an N-terminal deletion,”Gene112:29-38, Elsevier Science B.V. (1992).
Bennett, B.L., and Molenaar, A.J., “Cloning of PCR Products Can Be Inhibited byTaqPolymerase Carryover,”BioTechniques16:32, 37, BPA International (1994).
Boehringer Mannheim Reagents for Molecular Biology Catalog, 1990, pp. 15, 23, Boehringer Mannheim Gmbh (1990).
Dang, C., and Jayasena, S.D., “Oligonucleotide Inhibitors ofTaqDNA Polymerase Facilitate Detection of Low Copy Number Targets by PCR,”J. Mol. Biol. 264:268-278, Academic Press Ltd. (1996).
Flaman, J-M., et al., “A rapid PCR fidelity assay,”Nucl. Acids Res. 22:3259-3260, Oxford University Press (1994).
Fox, D., et al., “Prevention ofTaqDNA Polymerase-Mediated Artifacts in PCR Product Cloning,”FOCUS20:5-16, Bethesda Research Laboratories (Mar. 1998).
Gerard, G.F., “Reverse Transcriptase: A Historical Perspective,”FOCUS 20:65-67, Bethesda Research Laboratories (Fall 1998).
Innis, M.A., et al., “DNA sequencing withThermus aquaticusDNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA,”Proc. Natl. Acad. Sci. USA 85:9436-9440, National Academy of Sciences (Dec. 1998).
Kahl, G., “Dictionary of Gene Technology,” VCH Publishers, New York, NY, pp. 140, 411, 510 (1995).
Kainz, P., et al., “Specificity-Enhanced Hot-Start PCR: Addition of Double-Stranded DNA Fragments Adapted to the Annealing Temperature,”BioTechniques28:278-282, BPA International (Feb. 2000).
Kellogg, D.E., et al., “TaqStart Antibody™: ‘Hot-Start’ PCR Facilitated by a Neutralizing Monoclonal Antibody Directed AgainstTaqDNA Polymerase,”BioTechniques 16:1134-1137, BPA International (1994).
Life Technologies, Inc., “GIBCO BRL Products and Reference Guide 1997/1998,” pp. 19-18, 19-19, Invitrogen Corporation (1997).
Lawyer, F.C., et al., “High-level Expression, Purification, and Enzymatic Characterization of Full-lengthThermus aquaticusDNA Polymerase and a Truncated Form Deficient in 5′ to 3′ Exonuclease Activity,”PCR Meth. Appl. 2:275-287, Cold Spring Harbor Laboratory Press (1993).
Lin, Y., and Jayasena, S.D., “Inhibition of Multiple Thermostable DNA Polymerases by a Heterodimeric Aptamer,”J. Mol. Biol. 271:100-111, Academic Press Ltd. (Aug. 1997).
Newton, C.R., “Thermostable DNA Polymerase,” inPCR Essential Data, Newton, C.R., ed., John Wiley & Sons, New York, NY, pp. 37-48 (1995).
New England Biolabs, Beverly, MA, product information of VENT™, DEEPVENT™, and other thermophilic DNA polymerase, NEW 1996-1997 Products Catalogued, pp. 70-71, New England Biolabs, Inc. (1996).
Nilsson, J., et al., “Heat-Mediated Activation of Affinity-ImmobilizedTaqDNA Polymerase,”BioTechniques 22:744-751, Elsevier Science (Apr. 1997).
International Search Report for International Patent Application No. PCT/US98/17004, Nov. 19, 1998.
Holton and Graham, “A Simple and Efficient Method for Direct Cloning of PCR Products Using ddT-Tailed Vectors”,Nucl. Acids Res. 19 (5) 1991 , 1156.
Marchuk, et al., “Construction of T-Vectors, a Rapid and General System for Direct Cloning of Unmodified PCR Products”,Nucl. Acids Res. vol. 19 (5) Mar. 11, 1991 , 1154.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for cloning amplified nucleic acid molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for cloning amplified nucleic acid molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for cloning amplified nucleic acid molecules will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4165178

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.